Related Experiment Video

Updated: Aug 5, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Risk Stratification in Cardiovascular Medicine for Prognostic Assessment and Therapeutic Decision-Making: From Atrial

Yuichi Saito1, Kazuya Tateishi1, Ken Kato1

  • 1Department of Cardiovascular Medicine Chiba University Hospital Chiba Japan.

Journal of Arrhythmia
|July 30, 2026
PubMed

Insights

Cardiovascular risk scores are essential for diagnosis and treatment, but their clinical benefit requires evidence from implementation trials. Artificial intelligence may enhance future cardiovascular risk assessment and decision support.

Area of Science:

  • Cardiovascular Medicine
  • Medical Informatics

Background:

  • Validated risk stratification scoring systems are fundamental in cardiovascular medicine.
  • These scores guide diagnosis, treatment selection, and prognostic assessment for various cardiovascular diseases.

Purpose of the Study:

  • To provide a comprehensive overview of major cardiovascular risk scores.
  • To examine evidence on whether risk score-guided management improves clinical outcomes.
  • To discuss the future role of artificial intelligence in cardiovascular risk assessment.

Main Methods:

  • Review of major risk scores used in cardiovascular diseases (e.g., atrial fibrillation, acute coronary syndrome).
  • Examination of randomized implementation trials evaluating risk score-guided management.
  • Discussion of artificial intelligence applications in cardiovascular risk assessment.

Main Results:

  • Risk scores are crucial but predictive performance alone doesn't ensure clinical benefit.
  • Implementation trials are necessary to validate the clinical utility of risk score-guided management.
  • Artificial intelligence holds potential for dynamic, individualized cardiovascular risk prediction and decision support.

Conclusions:

  • Risk stratification is pivotal in cardiovascular medicine, requiring evidence beyond predictive accuracy.
  • Future cardiovascular risk assessment will likely integrate AI for enhanced clinical decision-making.

Keywords:
cardiovascular diseasediagnosisprognosisrisk score

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...